Literature DB >> 14699510

PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor.

Agnès Chompret1, Caroline Kannengiesser, Michel Barrois, Philippe Terrier, Philippe Dahan, Thomas Tursz, Gilbert M Lenoir, Brigitte Bressac-De Paillerets.   

Abstract

Familial gastrointestinal stromal tumor (GIST) is a rare autosomal dominant genetic disorder associated with KIT germline mutations. In sporadic forms of the disease, somatic mutations target either KIT or PDGFRA genes. In a kindred in which 5 individuals had GIST, no germline mutation in KIT coding sequence has been detected. We hypothesized that the PDGFRA gene could be a predisposing gene in familial GIST. We sequenced PDGFRA exons 12 and 18 because several somatic mutations were identified within this region. We detected a germline PDGFRA missense mutation, 2675G > T, resulting in a tyrosine substitution for the highly conserved aspartic acid at codon 846. This mutation showed perfect cosegregation with the GIST phenotype among the 7 family members tested. Interestingly, PDGFRA Asp846 is homologous to codon 820, which is located in the KIT tyrosine kinase II domain. In a previous study, a KIT germline Asp820Tyr mutation was detected in a Japanese kindred in which 6 individuals had GIST. Transfection of a KIT820Tyr complementary DNA in nude mice was found to be tumorigenic confirming the oncogenic potential of this mutation. The present study shows that PDGFRA is a second familial GIST predisposing gene. These results indicate a further example of involvement of structurally related genes in familial cancer syndromes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699510     DOI: 10.1053/j.gastro.2003.10.079

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  61 in total

1.  Advances in the surgical management of gastrointestinal stromal tumor.

Authors:  Umer I Chaudhry; Ronald P DeMatteo
Journal:  Adv Surg       Date:  2011

Review 2.  Gastrointestinal stromal tumors (GISTs): an updated experience.

Authors:  Anastasios Machairas; Eva Karamitopoulou; Dimitrios Tsapralis; Theodore Karatzas; Nickolas Machairas; Evangelos P Misiakos
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

Review 3.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

4.  The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.

Authors:  R Penzel; S Aulmann; M Moock; M Schwarzbach; R J Rieker; G Mechtersheimer
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

5.  Sporadic somatic mutation of c-kit gene in a family with gastrointestinal stromal tumors without cutaneous hyperpigmentation.

Authors:  Chun-Nan Yeh; Tsung-Wen Chen; Yi-Yin Jan
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

6.  Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.

Authors:  Nabeel Salmons; Richard J Gregg; Anna Pallalau; Ian Woolhouse; Ian Geh; Philippe Tanière
Journal:  J Clin Pathol       Date:  2007-02       Impact factor: 3.411

Review 7.  Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.

Authors:  S Farag; L E van der Kolk; H H van Boven; A C J van Akkooi; G L Beets; J W Wilmink; N Steeghs
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

8.  Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis.

Authors:  Lorin E Olson; Philippe Soriano
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

9.  Stromal, fibrous, and fatty gastrointestinal tumors in a patient with a PDGFRA gene mutation.

Authors:  J Aidan Carney; Constantine A Stratakis
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

10.  Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Authors:  James D Murphy; Grace L Ma; Joel M Baumgartner; Lisa Madlensky; Adam M Burgoyne; Chih-Min Tang; Maria Elena Martinez; Jason K Sicklick
Journal:  Cancer       Date:  2015-04-30       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.